NCT05348356
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05348356
Title Nirogacestat in Ovarian Granulosa Cell Tumors
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors SpringWorks Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | POL | CAN


No variant requirements are available.